Global Hospital-Acquired Infection Control Market , By Type , By Applications , By Regions – Global Forecast 2030

Market Overview –

According to Market Research Future, The Global Hospital-Acquired Infections Market is currently valued at USD 23.7 billion and is expected to reach USD 32,510.95 billion by 2030, growing at a CAGR of 1.37 percent over the forecast period (MRFR). Healthcare-associated infections (HAIs) or nosocomial infections are other terms for hospital-acquired infections (HAIs). It’s basically a type of infection that’s common in hospitals. In most cases, the patient is admitted to the hospital for a different illness, but the infection is picked up while they’re there. After being released from the hospital, patients are more likely to contract an infection or develop symptoms acquired while in the hospital. Hospital-acquired infections, on the other hand, are more effective after the patient has been discharged. There is also an occupational infection among hospital staff due to Hospital-Acquired Infections.

The Hospital-Acquired Infections can come from a variety of sources, including another infected patient, the outside environment, infected hospital staff, or other unknown sources. According to the World Health Organization (WHO), 8.7 percent of hospital patients had nosocomial infections, affecting nearly 1.4 million people worldwide.

But the Hospital-Acquired Infections Market Analysis report states that the intended audiences are driving the market’s growth in the forecast period. Suppliers of drugs for the treatment of hospital-acquired infections (HAIs), manufacturers of HAI treatment drugs and instruments, contract manufacturers, private research labs, government research labs, market research and consulting firms, and R&D firms are some of the intended recipients.

Market Dynamics –

Growth in the Hospital-Acquired Infections Market is due to environmental factors such as bacterial load and infected materials, hospital crowding and humidity among others. Lack of knowledge also contributes to the global market’s expansion.

Hospital-Acquired Infections Market Size is expected to grow during this time period due to factors such as increased patient susceptibility to infection, microbial virulence and nature, high prevalence of HAI, age of the patient, bacterial resistance to drugs, poor hospital infrastructure and regulation, increasing chronic diseases with prolonged medical stays, low healthcare expenditure, and others.

The number of surgical procedures performed around the world has increased significantly over the years. The WHO (2019) estimates that approximately 235 million major surgical procedures are carried out each year around the globe. Obesity and other lifestyle diseases are on the rise, the elderly population is on the rise, and spinal injuries and sports-related injuries are all on the rise.

COVID-19 Analysis –

Hospitals around the world are struggling to keep up with the increasing number of patients due to the pandemic. In order to deal with the increasing number of cases, temporary hospitals are also being built up. To put it another way, a rise in the number of hospital-acquired infections (HAIs) has resulted in an increase in the demand for HAI services.

As the current COVID-19 pandemic wreaks havoc around the world, businesses and government agencies alike are implementing a variety of strategies to spur growth in the market. As an example, Sterigenics’ ethylene oxide-based sterilisation factory in the United States has been recommended by the FDA for reopening. As a result of potentially cancer-causing pollutants, the facility was forced to close its doors. As soon as the COVID-19 pandemic hit in March 2020, the corporation was given authorization to open the plant for 21 days to sterilise personal protective equipment (PPE) for use by healthcare personnel. This market is expected to rise as a result of these advancements.

Sterilization of medical equipment is crucial in the fight against the spread of COVID-19 in hospitals. The spread of pathogens from one patient to the next via medical devices can be completely avoided during an outbreak if the gadgets are adequately sterilised. Reprocessed medical equipment is being used more frequently during the pandemic because incorrect decontamination of surgical instruments, endoscopic devices, respiratory care devices, and reusable hemodialysis machines can raise the risk of COVID-19 infection.

Competitive Landscape –

Competitive landscape of the global infection control market is fairly fragmented with many key players operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolios and gain a robust footing in the global market.

Top Key Players –

Becton
BioMérieux
BD
Advanced Sterilization Products
AbbVie
Cepheid
Alere
Bayer
Getinge Group
3M
Biomerieux SA
Abbott Laboratories

By Types –

Disinfectants
Sterilants
Other Products

By Applications –

Hospitals and Intensive Care Units
Ambulatory Surgical and Diagnostic Centers
Nursing Homes and Maternity Centers

By Regions –

North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others